VRTX Short-Term Debt

Vertex Pharmaceuticals · Short-Term Debt

VRTX logo

VRTX Short-Term Debt

Latest reported$82.80M
VRTX FY Short-Term Debt ($800.00K → $82.80M)
High-resolution chart · PNG

VRTX short-term debt history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Short-Term Debt — Annual fiscal periods (USD)
Period endingShort-Term Debt (USD)
82,800,000
92,300,000
83,700,000
89,400,000
80,200,000
42,400,000
38,794,000
5,271,000
22,531,000
319,426,000
86,841,000
32,012,000
16,893,000
13,707,000
0
136,991,000
64,142,000
0
19,997,000
103,758,000
0
0
4,660,000
2,195,000
4,579,000
-26,114,000
2,366,000
2,800,000
2,500,000
2,900,000
2,100,000
1,700,000
1,800,000
1,800,000
1,200,000
800,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.